Lack of responsiveness of a nuclear factor-kappaB-regulated promoter to transactivation by human immunodeficiency virus 1 Tat in HeLa cells

Virology. 1999 Oct 10;263(1):128-38. doi: 10.1006/viro.1999.9966.

Abstract

Transcriptional activation by Tat protein is in large part dependent on interactions with the TAR RNA element located in the 5'-untranslated region of all human immunodeficiency virus type 1 (HIV-1) transcripts. In addition, Tat has been shown to induce nuclear translocation of nuclear factor-kappaB (NF-kappaB), potentially contributing to gene induction. The NF-kappaB responsive reporter construct, (PRDII)(4)-CAT, was used to explore transcription resulting from NF-kappaB activated by Tat. Tat did not activate (PRDII)(4)-CAT, whereas (PRDII)(4)-CAT was highly responsive to either transfected Rel A or to tumor necrosis factor-alpha (TNF-alpha). Despite its inability to directly induce, Tat enhanced the responsiveness of (PRDII)(4)-CAT to either transfected Rel A or to TNF-alpha by approximately 2.5-fold. High levels of CAT activity were seen with HIV-LTR-derived reporters that contained kappaB and TAR elements in response to transfected Tat in the absence of either transfected Rel A or exogenous TNF-alpha, and overexpression of IkappaBalpha with Tat inhibited CAT activity by 60% to 80%, suggesting that some activation of NF-kappaB by Tat was occurring. HIV-LTR reporter activities were enhanced three fold to sixfold compared with Tat alone when additional NF-kappaB was provided by transfection or by activation with TNF-alpha. These data indicate that Tat is unable to activate some NF-kappaB-responsive promoters but is able to synergize with NF-kappaB in the activation of both HIV-derived and non-HIV-derived promoters.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Gene Expression Regulation, Viral
  • Gene Products, tat / genetics
  • Gene Products, tat / metabolism*
  • Genes, Reporter
  • HIV Long Terminal Repeat
  • HIV-1 / genetics*
  • HIV-1 / physiology
  • HeLa Cells
  • Humans
  • NF-kappa B / genetics
  • NF-kappa B / metabolism*
  • Plasmids / genetics
  • Promoter Regions, Genetic*
  • Transcription Factor RelA
  • Transcriptional Activation*
  • Transfection
  • Tumor Necrosis Factor-alpha / pharmacology
  • tat Gene Products, Human Immunodeficiency Virus

Substances

  • Gene Products, tat
  • NF-kappa B
  • Transcription Factor RelA
  • Tumor Necrosis Factor-alpha
  • tat Gene Products, Human Immunodeficiency Virus